These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 28526472)

  • 1. [Functional respiratory imaging after neostigmine- or sugammadex-enhanced recovery from neuromuscular blockade in the anesthetised rat: a randomised controlled pilot study].
    Schepens T; Cammu G; Maes S; Desmedt B; Vos W; Deseure K
    Rev Bras Anestesiol; 2017; 67(5):443-449. PubMed ID: 28526472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neostigmine but not sugammadex impairs upper airway dilator muscle activity and breathing.
    Eikermann M; Zaremba S; Malhotra A; Jordan AS; Rosow C; Chamberlin NL
    Br J Anaesth; 2008 Sep; 101(3):344-9. PubMed ID: 18559352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electromyographic activity of the diaphragm during neostigmine or sugammadex-enhanced recovery after neuromuscular blockade with rocuronium: a randomised controlled study in healthy volunteers.
    Schepens T; Cammu G; Saldien V; De Neve N; Jorens PG; Foubert L; Vercauteren M
    Eur J Anaesthesiol; 2015 Jan; 32(1):49-57. PubMed ID: 25111539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of Partial Neuromuscular Block and the Ventilatory Response to Hypoxia: A Randomized Controlled Trial in Healthy Volunteers.
    Broens SJL; Boon M; Martini CH; Niesters M; van Velzen M; Aarts LPHJ; Dahan A
    Anesthesiology; 2019 Sep; 131(3):467-476. PubMed ID: 31045894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recovery of muscle function after deep neuromuscular block by means of diaphragm ultrasonography and adductor of pollicis acceleromyography with comparison of neostigmine vs. sugammadex as reversal drugs: study protocol for a randomized controlled trial.
    Cappellini I; Picciafuochi F; Ostento D; Danti G; De Gaudio AR; Adembri C
    Trials; 2018 Feb; 19(1):135. PubMed ID: 29467022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomised controlled trial of sugammadex or neostigmine for reversal of neuromuscular block on the incidence of pulmonary complications in older adults undergoing prolonged surgery.
    Togioka BM; Yanez D; Aziz MF; Higgins JR; Tekkali P; Treggiari MM
    Br J Anaesth; 2020 May; 124(5):553-561. PubMed ID: 32139135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diaphragmatic and intercostal electromyographic activity during neostigmine, sugammadex and neostigmine-sugammadex-enhanced recovery after neuromuscular blockade: A randomised controlled volunteer study.
    Cammu G; Schepens T; De Neve N; Wildemeersch D; Foubert L; Jorens PG
    Eur J Anaesthesiol; 2017 Jan; 34(1):8-15. PubMed ID: 27902641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sugammadex antagonism of rocuronium-induced neuromuscular blockade in patients with liver cirrhosis undergoing liver resection: a randomized controlled study.
    Abdulatif M; Lotfy M; Mousa M; Afifi MH; Yassen K
    Minerva Anestesiol; 2018 Aug; 84(8):929-937. PubMed ID: 29405667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respiratory muscle activity after spontaneous, neostigmine- or sugammadex-enhanced recovery of neuromuscular blockade: a double blind prospective randomized controlled trial.
    Schepens T; Janssens K; Maes S; Wildemeersch D; Vellinga J; Jorens PG; Saldien V
    BMC Anesthesiol; 2019 Oct; 19(1):187. PubMed ID: 31629404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SUGAMMADEX versus neostigmine after ROCURONIUM continuous infusion in patients undergoing liver transplantation.
    Deana C; Barbariol F; D'Incà S; Pompei L; Rocca GD
    BMC Anesthesiol; 2020 Mar; 20(1):70. PubMed ID: 32213163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unwarranted administration of acetylcholinesterase inhibitors can impair genioglossus and diaphragm muscle function.
    Eikermann M; Fassbender P; Malhotra A; Takahashi M; Kubo S; Jordan AS; Gautam S; White DP; Chamberlin NL
    Anesthesiology; 2007 Oct; 107(4):621-9. PubMed ID: 17893459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block.
    Kotake Y; Ochiai R; Suzuki T; Ogawa S; Takagi S; Ozaki M; Nakatsuka I; Takeda J
    Anesth Analg; 2013 Aug; 117(2):345-51. PubMed ID: 23757472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recovery characteristics of patients receiving either sugammadex or neostigmine and glycopyrrolate for reversal of neuromuscular block: a randomised controlled trial.
    Paech MJ; Kaye R; Baber C; Nathan EA
    Anaesthesia; 2018 Mar; 73(3):340-347. PubMed ID: 29214645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sugammadex and neostigmine dose-finding study for reversal of residual neuromuscular block at a train-of-four ratio of 0.2 (SUNDRO20)†,
    Kaufhold N; Schaller SJ; Stäuble CG; Baumüller E; Ulm K; Blobner M; Fink H
    Br J Anaesth; 2016 Feb; 116(2):233-40. PubMed ID: 26787792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sugammadex Versus Neostigmine for Recovery of Respiratory Muscle Strength Measured by Ultrasonography in the Postextubation Period: A Randomized Controlled Trial.
    Huang C; Wang X; Gao S; Luo W; Zhao X; Zhou Q; Huang W; Xiao Y
    Anesth Analg; 2023 Mar; 136(3):559-568. PubMed ID: 36279410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of protracted dexamethasone exposure and its withdrawal on rocuronium-induced neuromuscular blockade and sugammadex reversal: an ex vivo rat study.
    Oh SK; Lim BG; Park S; Yang HS; In J; Kim YB; Choi HR; Lee IO
    Sci Rep; 2019 Aug; 9(1):11268. PubMed ID: 31375743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of reversal with neostigmine of low-dose rocuronium vs. reversal with sugammadex of high-dose rocuronium for a short procedure.
    Choi ES; Oh AY; Koo BW; Hwang JW; Han JW; Seo KS; Ahn SH; Jeong WJ
    Anaesthesia; 2017 Oct; 72(10):1185-1190. PubMed ID: 28493510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective study of residual neuromuscular block and postoperative respiratory complications in patients reversed with neostigmine versus sugammadex.
    Martinez-Ubieto J; Ortega-Lucea S; Pascual-Bellosta A; Arazo-Iglesias I; Gil-Bona J; Jimenez-Bernardó T; Muñoz-Rodriguez L
    Minerva Anestesiol; 2016 Jul; 82(7):735-42. PubMed ID: 26472231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recovery of early postoperative muscle strength after deep neuromuscular block by means of ultrasonography with comparison of neostigmine versus sugammadex as reversal drugs: study protocol for a randomised controlled trial.
    Wang X; Li Y; Huang C; Xiong W; Zhou Q; Niu L; Xiao Y
    BMJ Open; 2021 Feb; 11(2):e043935. PubMed ID: 33637547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine.
    Jones RK; Caldwell JE; Brull SJ; Soto RG
    Anesthesiology; 2008 Nov; 109(5):816-24. PubMed ID: 18946293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.